-
psnet.ahrq.gov/web-mm/managing-complexity-diagnosis-life-threatening-complications-after-gastric-bypass-surgery
September 25, 2019 - Neuropsychiatric and neuropsychological aspects of alcohol-related cognitive disorders: an in-depth review
-
meps.ahrq.gov/data_files/publications/st541/stat541.shtml
March 01, 2022 - recommended as the first-line treatment
for most types of pain due to serious risks of opioid use disorders
-
psnet.ahrq.gov/web-mm/delayed-diagnosis-setting-virtual-care-remembering-physical-examination
April 29, 2020 - resulting in loss of vision, paralysis, sensory loss, ataxia, adverse brainstem signs, psychiatric disorders
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/thMRXgCVQmNUsYo6dmXEc3
May 01, 2004 - Photorefractor for
detection of treatable eye disorders in preverbal
children.
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/model/evidence-now-sustainable-funding-resource.pdf
February 01, 2023 - chronic disease management and to design and implement systems to
screen for alcohol and substance use disorders
-
psnet.ahrq.gov/web-mm/fatal-twist-pseudohyperkalemia
February 10, 2021 - Potassium disorders: hypokalemia and hyperkalemia.
-
hcup-us.ahrq.gov/reports/statbriefs/sb151.jsp
March 01, 2013 - changes in rates for long-term diabetes complications (i.e., renal, visual, neurological, and circulatory disorders
-
hcup-us.ahrq.gov/reports/statbriefs/sb116.pdf
June 14, 2011 - 3,977,790 4.3
Headache; including migraine 4 223,327 3.6 7 2,465,250 2.7
Spondylosis; intervertebral disc disorders
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-215-fullreport.pdf
August 01, 2017 - Sickle Cell Disease Prevalence and Incidence
SCD is one of the most common genetic disorders in the
-
www.ahrq.gov/sites/default/files/2024-01/lo-report.pdf
January 01, 2024 - Drug-induced liver disorders: implications for drug development and
regulation. … Liver disorders in patients receiving
chlorpromazine or isoniazid.
-
effectivehealthcare.ahrq.gov/products/women-hiv/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - Investigator Other
Experts
Conclusion from
SCEPC
Validity of CER conclusion(s)
mg/kg/week) for disorders … incidence from non-CF patients receiving modest doses of rhGH (0.2 mg/kg/week to 0.6
mg/kg/week) for disorders … (Pfizer
Database) 18
KIGS database
was established
in 1987 to
monitor
children with
growth
disorders … incidence from non-CF patients receiving modest doses of rhGH (0.2 mg/kg/week to 0.6 mg/kg/week) for
disorders
-
hcup-us.ahrq.gov/db/nation/nis/NISIntroduction2010.pdf
November 01, 2015 - , (1) Comorbidity is
present
CM_LYTES 2002-2010 AHRQ comorbidity measure: Fluid and electrolyte
disorders … (1) Comorbidity is
present
CM_PERIVASC 2002-2010 AHRQ comorbidity measure: Peripheral vascular
disorders … ) Comorbidity is
present
CM_PULMCIRC 2002-2010 AHRQ comorbidity measure: Pulmonary circulation
disorders … parasitic disease, (2)
Neoplasms, (3) Endocrine, nutritional, and metabolic
diseases and immunity disorders … , (4) Diseases of
blood and blood-forming organs, (5) Mental
disorders, (6) Diseases of the nervous
-
hcup-us.ahrq.gov/db/nation/nis/NIS_2009_INTRODUCTION.pdf
January 01, 2009 - , (1) Comorbidity is
present
CM_LYTES 2002-2009 AHRQ comorbidity measure: Fluid and electrolyte
disorders … (1) Comorbidity is
present
CM_PERIVASC 2002-2009 AHRQ comorbidity measure: Peripheral vascular
disorders … ) Comorbidity is
present
CM_PULMCIRC 2002-2009 AHRQ comorbidity measure: Pulmonary circulation
disorders … parasitic disease, (2)
Neoplasms, (3) Endocrine, nutritional, and metabolic
diseases and immunity disorders … , (4) Diseases of
blood and blood-forming organs, (5) Mental
disorders, (6) Diseases of the nervous
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2011.pdf
January 01, 2011 - , (1) Comorbidity is
present
CM_LYTES 2002-2011 AHRQ comorbidity measure: Fluid and electrolyte
disorders … (1) Comorbidity is
present
CM_PERIVASC 2002-2011 AHRQ comorbidity measure: Peripheral vascular
disorders … ) Comorbidity is
present
CM_PULMCIRC 2002-2011 AHRQ comorbidity measure: Pulmonary circulation
disorders … parasitic disease, (2)
Neoplasms, (3) Endocrine, nutritional, and metabolic
diseases and immunity disorders … , (4) Diseases of
blood and blood-forming organs, (5) Mental
disorders, (6) Diseases of the nervous
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/smoking-pregnancy-infants_research-protocol.pdf
March 11, 2013 - Smoking patterns and outcomes in a population of pregnant women
with other substance use disorders. … [Conduct disorders in seven-year-old children—results of ELSPAC study. 3. Postnatal
development].
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
January 01, 2020 - CDS Connect Maintenance and Update Final Report Year 4 2020
CDS Connect
CDS Connect
Maintenance and
Update
Final Report
(Year 4 of CDS Connect)
Final Report (Year 4 of CDS Connect)
CDS Connect Maintenance and Update
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
…
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year4-final-report-2020.pdf
January 01, 2020 - CDS Connect Maintenance and Update Final Report Year 4 2020
CDS Connect
CDS Connect
Maintenance and
Update
Final Report
(Year 4 of CDS Connect)
Final Report (Year 4 of CDS Connect)
CDS Connect Maintenance and Update
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - CER 215 Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Adverse Effects of Pharmacologic Treatments of Major Depression
in Older Adults
Draft review available for public comment from May 13, 201…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
March 21, 2013 - Peer reviewer #7
(TEP)
Executive Summary
ES-1 l. 40
anovulatory doesn’t mean ovulatory disorders … Investigators did not systematically evaluate
for the presence of disorders of hemostasis.